Metharbital

Metharbital.svg

Metharbital is a barbiturate derivative that has been used as an anticonvulsant in the treatment of epilepsy. It is known for its sedative and hypnotic properties, which make it effective in managing seizures and other related conditions.

Pharmacology

Metharbital works by depressing the central nervous system (CNS), which helps to reduce the frequency and severity of seizures. It enhances the activity of the gamma-aminobutyric acid (GABA) neurotransmitter, which is an inhibitory neurotransmitter in the CNS. This action helps to stabilize neuronal activity and prevent the abnormal electrical discharges that cause seizures.

Medical Uses

Metharbital is primarily used in the management of epilepsy, particularly in patients who do not respond well to other anticonvulsant medications. It may also be used for its sedative properties in the treatment of anxiety and insomnia.

Side Effects

Common side effects of metharbital include drowsiness, dizziness, and ataxia. Long-term use can lead to tolerance and dependence, and abrupt discontinuation may result in withdrawal symptoms. Other potential side effects include nausea, vomiting, and headache.

Contraindications

Metharbital is contraindicated in patients with a history of porphyria, severe liver disease, or respiratory depression. It should be used with caution in patients with a history of substance abuse or mental health disorders.

Dosage

The dosage of metharbital varies depending on the patient's age, weight, and the severity of the condition being treated. It is typically administered orally in tablet form, and the dosage must be carefully adjusted to achieve the desired therapeutic effect while minimizing side effects.

History

Metharbital was first synthesized in the early 20th century and has been used in clinical practice for several decades. Its use has declined with the development of newer anticonvulsant medications that have fewer side effects and a lower potential for abuse.

See Also

• Barbiturate
• Anticonvulsant
• Epilepsy
• Gamma-aminobutyric acid
• Central nervous system